Dating sites south africa hiv
Dating sites south africa hiv - Adult Chat Rooms
With an active presence in some 76 countries, Aspen manufactures approximately 23 billion tablets annually at its 26 manufacturing facilities at 18 sites on 6 continents.Scientists will conduct a trial of an experimental HIV vaccine in South Africa later this year. The trial will include 5,400 healthy volunteers from 18-35 who are at risk of HIV who will receive five injections over a year, vaccine or a placebo. The shots will contain HIV vaccine used in Thailand in 2009 -- the only vaccine that has shown marginal effectiveness.
A two-vaccine combination cut the risk of HIV infection by 31 percent over 3 1/2 years, but it was more effective the first year.NIH said a small safety trial in South Africa showed promising enough results for a wider study."For the first time in seven years, the scientific community is embarking on a large-scale clinical trial of an HIV vaccine, the product of years of study and experimentation," said Anthony S. D., director of NIAID, part of the National Institutes of Health and trial co-funder."A safe and effective HIV vaccine could help bring about a durable end to the HIV/AIDS pandemic and is particularly needed in southern Africa, where HIV is more pervasive than anywhere else in the world." The National Institute of Allergy and Infectious Diseases and its partners have decided to conduct the larger clinical trial called HVTN 702.The vaccine regimen consists of two experimental vaccines, one that is canarypox-based and another that enhances the body's immune response to a vaccine.South African-based JSE Limited listed Aspen continues to increase the number of lives benefiting from its products, reaching more than 150 countries across the world.
The extensive basket of Aspen products provides treatment for a broad spectrum of acute and chronic conditions experienced throughout all stages of life.
Aspen is a global supplier of branded and generic pharmaceutical products as well as infant nutritional and consumer healthcare products in selected territories.
The Group has an extensive global presence with more than 10 000 employees.
"While we are making encouraging progress – new HIV infections have fallen by 35 percent globally since 2000 – the development of a safe and effective HIV vaccine would be the ultimate game- changer," Fauci wrote on the NIAID website.
The study will be led by Glenda Gray, president and chief executive officer of the South African Medical Research Council.
It is estimated that 12.2 percent of the South African population (6.4 million persons) are HIV positive, according to United Nations Population Fund.